Case report

Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation

Yao J, Wang A, Wang X, Zhang L, Zhu Y, Ou Y, Wang Z, Yang Y

OncoTargets and Therapy 2019, 12:4261-4267

Published Date: 29 May 2019